Evox Therapeutics announced today that it raised $95.4 million (£69.2 million) in a Series C financing round.
Oxford, England-based Evox’s financing was significantly oversubscribed with high demand from both existing and new investors, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.